HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcel Levi Selected Research

Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)

6/2021Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.
1/2020Coagulopathy of Coronavirus Disease 2019.
1/2014Recombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial.
8/2012Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study.
7/2008The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcel Levi Research Topics

Disease

72Sepsis (Septicemia)
02/2024 - 01/2002
57Inflammation (Inflammations)
01/2024 - 05/2002
51Disseminated Intravascular Coagulation
11/2023 - 01/2002
51Hemorrhage
11/2023 - 11/2002
34Thrombosis (Thrombus)
10/2023 - 01/2002
31Infections
02/2024 - 04/2002
23Pneumonia (Pneumonitis)
01/2021 - 04/2002
18COVID-19
02/2024 - 01/2020
15Wounds and Injuries (Trauma)
10/2023 - 04/2005
14Neoplasms (Cancer)
06/2021 - 03/2002
13Thrombocytopenia (Thrombopenia)
10/2022 - 03/2002
12Critical Illness (Critically Ill)
01/2021 - 01/2006
11Pneumococcal Pneumonia
03/2015 - 04/2002
11Acute Lung Injury
01/2013 - 05/2003
10Endotoxemia
09/2012 - 10/2002
9Hereditary Angioedemas
01/2023 - 10/2005
9Venous Thromboembolism
06/2021 - 03/2002
9Lung Injury
11/2017 - 10/2006
7Angioedema
11/2022 - 04/2006
7Thrombotic Microangiopathies
07/2020 - 11/2003
7Ischemia
01/2017 - 03/2002
7Acute Coronary Syndrome
12/2011 - 02/2002
6Venous Thrombosis (Deep-Vein Thrombosis)
10/2022 - 01/2002
6Atrial Fibrillation
09/2011 - 02/2004
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2021 - 07/2008
5Delirium
10/2014 - 05/2007
5Stroke (Strokes)
09/2009 - 02/2004
4Shock
03/2023 - 05/2008
4Thromboembolism
01/2020 - 02/2004
4Human Influenza (Influenza)
10/2011 - 11/2006
4Hyperglycemia
07/2008 - 02/2006
4Peritonitis
05/2007 - 06/2004
3Communicable Diseases (Infectious Diseases)
02/2024 - 04/2013
3Multiple Organ Failure (MODS)
11/2023 - 02/2005
3Disease Progression
01/2023 - 06/2019
3Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2022 - 01/2021
3Hemophilia A (Haemophilia)
07/2020 - 04/2005
3Acquired angioedema
01/2019 - 04/2006
3Cardiovascular Diseases (Cardiovascular Disease)
06/2014 - 05/2008
3Melioidosis
01/2013 - 03/2010

Drug/Important Bio-Agent (IBA)

53AnticoagulantsIBA
01/2022 - 11/2002
45Dacarbazine (DIC)FDA LinkGeneric
11/2023 - 01/2002
33Protein CIBA
11/2017 - 06/2003
32FibrinIBA
06/2021 - 12/2002
30ThrombinFDA Link
10/2023 - 03/2002
26AntithrombinsIBA
08/2023 - 06/2004
23Thromboplastin (Tissue Factor)IBA
10/2023 - 02/2002
21Hemostatics (Antihemorrhagics)IBA
02/2024 - 05/2002
20Heparin (Liquaemin)FDA LinkGeneric
08/2023 - 01/2002
18CytokinesIBA
01/2024 - 05/2002
15Blood Coagulation Factors (Coagulation Factor)IBA
11/2022 - 08/2003
12Proteins (Proteins, Gene)FDA Link
06/2019 - 04/2003
9fibrin fragment D (D-dimer)IBA
02/2022 - 04/2003
8Interleukin-6 (Interleukin 6)IBA
02/2022 - 03/2004
8Factor VIIa (Activated Factor VII)IBA
11/2010 - 01/2003
7ThrombomodulinIBA
08/2023 - 07/2010
7Plasminogen InactivatorsIBA
03/2015 - 08/2003
7recombinant FVIIa (rFVIIa)FDA Link
11/2010 - 11/2002
6Biomarkers (Surrogate Marker)IBA
01/2023 - 02/2005
6FibrinolysinFDA Link
10/2019 - 03/2004
6Fibrin Fibrinogen Degradation ProductsIBA
10/2011 - 04/2003
6drotrecogin alfa activated (Xigris)FDA Link
01/2011 - 10/2005
5ChemokinesIBA
01/2024 - 10/2005
5PlasminogenIBA
10/2019 - 08/2003
5danaparoid (Orgaran)FDA Link
11/2017 - 01/2009
5Plasminogen Activators (Plasminogen Activator)IBA
10/2012 - 04/2002
5Prothrombin (Factor II)IBA
05/2011 - 10/2005
4Proteinase-Activated ReceptorsIBA
10/2023 - 03/2008
4ChAdOx1 nCoV-19IBA
01/2022 - 01/2021
4von Willebrand FactorIBA
07/2020 - 04/2008
4antithrombin III-protease complexIBA
01/2020 - 04/2003
4Fibrinogen (Factor I)FDA Link
01/2020 - 04/2003
4lipoprotein-associated coagulation inhibitor (TFPI)IBA
11/2017 - 08/2002
4Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2016 - 03/2002
4Peptide Hydrolases (Proteases)FDA Link
01/2016 - 01/2004
4LipopolysaccharidesIBA
01/2013 - 09/2008
4CoagulantsIBA
08/2012 - 05/2006
4Plasminogen Activator Inhibitor 1IBA
07/2012 - 08/2003
4Antifibrinolytic Agents (Antifibrinolytics)IBA
06/2012 - 01/2006
4Vitamin KFDA Link
10/2010 - 05/2008
4EndotoxinsIBA
07/2008 - 06/2003
3Oxygen (Dioxygen)IBA
02/2024 - 11/2006
3VaccinesIBA
10/2022 - 10/2021
3tocilizumab (atlizumab)FDA Link
01/2022 - 01/2020
3Messenger RNA (mRNA)IBA
01/2022 - 08/2003
3Complement System Proteins (Complement)IBA
10/2019 - 10/2007
3Peptides (Polypeptides)IBA
11/2017 - 10/2002
3Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 01/2010
3Factor Xa InhibitorsIBA
08/2016 - 11/2002
3Enoxaparin (Lovenox)FDA LinkGeneric
03/2016 - 08/2003
3Endothelial Protein C ReceptorIBA
05/2014 - 09/2012
3factor V LeidenIBA
07/2013 - 01/2010
3Interleukin-8 (Interleukin 8)IBA
10/2012 - 05/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
07/2012 - 01/2006
3Saline SolutionIBA
10/2011 - 06/2004

Therapy/Procedure

27Therapeutics
11/2022 - 03/2002
5Drug Therapy (Chemotherapy)
06/2021 - 03/2002
5Artificial Respiration (Mechanical Ventilation)
12/2012 - 09/2005
4Critical Care (Surgical Intensive Care)
01/2020 - 09/2005
3Stents
12/2011 - 01/2009